RESUMEN
INTRODUCTION: Infertility treatment with assisted reproductive technologies (ARTs) has been associated with adverse vascular events in some but not all previous studies. Endothelial damage, prothrombotic factor release, and a higher prevalence of cardiovascular risk factors in those receiving ART have been invoked to explain this association. We sought to explore the relationship between ART and stroke risk using population-level data. METHODS: We conducted a retrospective cohort study using data from the National Inpatient Sample registry from 2015 to 2020, including all delivery hospitalizations for patients aged 15 to 55 years. The study exposure was use of ART. The primary end point was any stroke defined as ischemic stroke, subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral venous thrombosis during index delivery hospitalization. Individual stroke subtypes (ischemic stroke, subarachnoid hemorrhage, intracerebral hemorrhage, and cerebral venous thrombosis) were evaluated as secondary end points. Standard International Classification of Diseases, Tenth Revision, Clinical Modification algorithms were used to define study exposure, comorbidities, and prespecified end points. In addition to reporting population-level estimates, propensity score adjustment by inverse probability weighting was used to mimic the effects of randomization by balancing baseline clinical characteristics associated with stroke between ART and non-ART users. RESULTS: Among 19â 123â 125 delivery hospitalizations identified, patients with prior ART (n=202â 815, 1.1%) experienced significantly higher rates of any stroke (27.1/100â 000 versus 9.1/100â 000), ischemic stroke (9.9/100â 000 versus 3.3/100â 000), subarachnoid hemorrhage (7.4/100â 000 versus 1.6/100â 000), intracerebral hemorrhage (7.4/100â 000 versus 2.0/100â 000), and cerebral venous thrombosis (7.4/100â 000 versus 2.7/100â 000) in comparison to non-ART users (all P<0.001 for all unadjusted comparisons). Following inverse probability weighting analysis, ART was associated with increased odds of any stroke (adjusted odds ratios, 2.14 (95% CI, 2.02-2.26); P<0.001). CONCLUSIONS: Using population-level data among patients hospitalized for delivery in the United States, we found an association between ART and stroke after adjustment for measured confounders.
Asunto(s)
Accidente Cerebrovascular Isquémico , Accidente Cerebrovascular , Hemorragia Subaracnoidea , Trombosis de la Vena , Humanos , Estados Unidos/epidemiología , Estudios Retrospectivos , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/terapia , Hemorragia Cerebral/epidemiología , Hemorragia Subaracnoidea/epidemiología , Hospitalización , Prevalencia , Técnicas Reproductivas Asistidas/efectos adversos , Trombosis de la Vena/epidemiologíaRESUMEN
BACKGROUND: Continued smoking after stroke is associated with a high risk of stroke recurrence and other cardiovascular disease. We sought to comprehensively understand the epidemiology of smoking cessation in stroke survivors in the United States. Furthermore, we compared smoking cessation in stroke and cancer survivors because cancer is another smoking-related condition in which smoking cessation is prioritized. METHODS: We performed a cross-sectional analysis of data from the Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System, an annual, nationally representative health survey. Using pooled data from 2013 to 2019, we identified stroke and cancer survivors with a history of smoking. We used survey procedures to estimate frequencies and summarize quit ratios with attention to demographic and geographic (state-wise and rural-urban) factors for stroke survivors. The quit ratio is conventionally defined as the proportion of ever smokers who have quit. Then, we used multivariable logistic regression to compare quit ratios in stroke and cancer survivors while adjusting for demographics and smoking-related comorbidities. RESULTS: Among 4 434 604 Americans with a history of stroke and smoking, the median age was 68 years (interquartile range, 59-76), and 45.4% were women. The overall quit ratio was 60.8% (95% CI, 60.1%-61.6%). Quit ratios varied by age group, sex, race and ethnicity, and several geographic factors. There was marked geographic variation in quit ratios, ranging from 48.3% in Kentucky to 71.5% in California. Furthermore, compared with cancer survivors, stroke survivors were less likely to have quit smoking (odds ratio, 0.72 [95% CI, 0.67-0.79]) after accounting for differences in demographics and smoking-related comorbidities. CONCLUSIONS: There were considerable demographic and geographic disparities in smoking quit ratios in stroke survivors, who were less likely to have quit smoking than cancer survivors. A targeted initiative is needed to improve smoking cessation for stroke survivors.
Asunto(s)
Cese del Hábito de Fumar , Accidente Cerebrovascular , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Fumar/epidemiología , Cese del Hábito de Fumar/métodos , Accidente Cerebrovascular/epidemiología , Sobrevivientes , Estados Unidos/epidemiologíaRESUMEN
A 30-year-old woman with progressive vision loss was found to have asymptomatic, bilateral, and symmetric basal ganglia lesions on MRI and was later diagnosed with Leber hereditary optic neuropathy (LHON). The rare occurrence of basal ganglia changes on MRI in patients with LHON is discussed.
Asunto(s)
Ganglios Basales/patología , Ceguera/etiología , Atrofia Óptica Hereditaria de Leber/complicaciones , Agudeza Visual , Adulto , Ceguera/diagnóstico , Ceguera/fisiopatología , Progresión de la Enfermedad , Femenino , Humanos , Imagen por Resonancia Magnética , Atrofia Óptica Hereditaria de Leber/diagnóstico , Atrofia Óptica Hereditaria de Leber/fisiopatología , Quiasma Óptico/patología , Nervio Óptico/patologíaRESUMEN
BACKGROUND: Rates of dual antiplatelet therapy (DAPT) after high-risk transient ischemic attack or minor ischemic stroke (TIAMIS) are suboptimal. We performed a cost-effectiveness analysis to characterize the parameters of a quality improvement (QI) intervention designed to increase DAPT use after TIAMIS. METHODS AND RESULTS: We constructed a decision tree model that compared current national rates of DAPT use after TIAMIS with rates after implementing a theoretical QI intervention designed to increase appropriate DAPT use. The base case assumed that a QI intervention increased the rate of DAPT use to 65% from 45%. Costs (payer and societal) and outcomes (stroke, myocardial infarction, major bleed, or death) were modeled using a lifetime horizon. An incremental cost-effectiveness ratio <$100 000 per quality-adjusted life year was considered cost-effective. Deterministic and probabilistic sensitivity analyses were performed. From the payer perspective, a QI intervention was associated with $9657 in lifetime cost savings and 0.18 more quality-adjusted life years compared with current national treatment rates. A QI intervention was cost-effective in 73% of probabilistic sensitivity analysis iterations. Results were similar from the societal perspective. The maximum acceptable, initial, 1-time payer cost of a QI intervention was $28 032 per patient. A QI intervention that increased DAPT use to at least 51% was cost-effective in the base case. CONCLUSIONS: Increasing DAPT use after TIAMIS with a QI intervention is cost-effective over a wide range of costs and proportion of patients with TIAMIS treated with DAPT after implementation of a QI intervention. Our results support the development of future interventions focused on increasing DAPT use after TIAMIS.
Asunto(s)
Ataque Isquémico Transitorio , Accidente Cerebrovascular , Humanos , Ataque Isquémico Transitorio/tratamiento farmacológico , Inhibidores de Agregación Plaquetaria/efectos adversos , Análisis Costo-Beneficio , Análisis de Costo-Efectividad , Accidente Cerebrovascular/tratamiento farmacológico , Accidente Cerebrovascular/inducido químicamenteRESUMEN
The grim circumstances of the COVID-19 pandemic have highlighted the need to refine and adapt stroke systems of care. Patients' care-seeking behaviors have changed due to perceived risks of in-hospital treatment during the pandemic. In response to these challenges, we optimized a recently implemented, novel outpatient approach for the evaluation and management of minor stroke and transient ischemic attack, entitled RESCUE-TIA. This modified approach incorporated telemedicine visits and remote testing, and proved valuable during the pandemic. In this review article, we provide the evidence-based rationale for our approach, describe its operationalization, and provide data from our initial experience.
RESUMEN
PURPOSE OF REVIEW: This article describes the neurologic sequelae of various nutritional micronutrient deficiencies, celiac disease, inflammatory bowel disease, and liver disease. Where relevant, appropriate treatments for these conditions are also discussed. The developing field of the microbiome and nervous system interaction is also outlined. RECENT FINDINGS: Pathology in the gastrointestinal system can affect the nervous system when it causes micronutrient deficiency, when immune responses created by the gastrointestinal system affect the nervous system, when toxins caused by gastrointestinal organ failure harm the nervous system, and when treatments aimed at a gastrointestinal medical condition cause damage to the nervous system as a side effect. SUMMARY: This article addresses familiar concepts and new developments in the treatment and understanding of diseases that affect the gut and nervous system simultaneously.
Asunto(s)
Enfermedades Gastrointestinales/complicaciones , Microbioma Gastrointestinal , Enfermedades del Sistema Nervioso/etiología , HumanosRESUMEN
OBJECTIVE: To report four patients with coronavirus disease 2019 (COVID-19) who developed posterior reversible encephalopathy syndrome (PRES). METHODS: Patient data was abstracted from medical records at Weill Cornell Medical Center. RESULTS: Four patients with SARS-CoV-2 infection and PRES were identified. The patients' ages ranged from 64 to 74 years, and two were women. All four patients were admitted to the hospital with acute respiratory distress syndrome requiring intensive care unit admission and mechanical ventilation. PRES was diagnosed after persistent confusion, lethargy, new focal neurological deficits, or seizures were noted, with evidence of seizures on electroencephalogram for two of the patients. Imaging confirmed the presence of cerebral vasogenic edema. All four patients had elevated blood pressure and renal injury in the days preceding PRES diagnosis, as well as evidence of systemic inflammation and systemic hypercoagulability. Symptoms of PRES improved with blood pressure control. CONCLUSIONS: Our four cases demonstrate the occurrence of PRES in critically-ill patients with COVID-19. PRES should be considered in the differential for acute neurological deficits and seizures in this setting.
Asunto(s)
COVID-19/complicaciones , Síndrome de Leucoencefalopatía Posterior/complicaciones , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
BACKGROUND: Dietary fat intake is associated with coronary heart disease risk, but the relationship between fat intake and ischemic stroke risk remains unclear. We hypothesized that total dietary fat as part of a Western diet is associated with increased risk of ischemic stroke. METHODS: As part of the prospective Northern Manhattan Study, 3,183 stroke-free community residents over 40 years of age underwent evaluation of their medical history and had their diet assessed by a food-frequency survey. Cox proportional hazard models calculated risk of incident ischemic stroke. RESULTS: The mean age of participants was 69 years, 63% were women, 21% were white, 24% black and 52% Hispanic. During a mean of 5.5 years of follow-up, 142 ischemic strokes occurred. After adjusting for potential confounders, risk of ischemic stroke was higher in the upper quintile of total fat intake compared to the lowest quintile (HR 1.6, 95% CI 1.0-2.7). Total fat intake >65 g was associated with increased risk of ischemic stroke (HR 1.6, 95% CI 1.2-2.3). Risk was attenuated after controlling for caloric intake. CONCLUSIONS: The results suggest that increased daily total fat intake, especially above 65 g, significantly increases risk of ischemic stroke.
Asunto(s)
Isquemia Encefálica/epidemiología , Grasas de la Dieta/administración & dosificación , Accidente Cerebrovascular/epidemiología , Factores de Edad , Anciano , Índice de Masa Corporal , Dieta , Ingestión de Energía , Femenino , Estudios de Seguimiento , Humanos , Masculino , Ciudad de Nueva York/epidemiología , Evaluación Nutricional , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Factores de Riesgo , Factores Socioeconómicos , Encuestas y CuestionariosRESUMEN
BACKGROUND AND OBJECTIVE: Lateropulsion after stroke has not been tracked using a case-matched controlled study and a standardized lateropulsion scale. Matched pairs of patients with stroke, with and without lateropulsion, were compared for functional outcomes and discharge destination following inpatient rehabilitation. METHODS: A retrospective chart review of patients with ischemic stroke at an inpatient rehabilitation hospital matched 36 pairs of patients with versus without lateropulsion. Scores of 2 or greater on the Burke Lateropulsion Scale identified lateropulsion. Matching criteria were side of stroke, sex, age, admission motor Functional Independence Measure (FIM), and interval poststroke. FIM efficiency (change in total FIM/length of stay) and discharge destination were analyzed with Wilcoxon signed-ranks tests. RESULTS: FIM efficiency and discharge FIM scores were lower in the lateropulsion group. Groups had similar mean lengths of stay. Post-hoc analyses showed that only patients with lateropulsion and right brain damage had significantly different FIM efficiency and discharge FIM scores. Lower extremity weakness was greater in the lateropulsion group at discharge; patients with right brain damage accounted for this difference. Patients with lateropulsion required more dependent living situations at discharge, especially if they had right brain damage. CONCLUSIONS: Patients with lateropulsion following stroke have a lower FIM efficiency and more dependency at discharge when compared with matched controls with equal functional limitations. Secondary analyses show worse outcomes for the subgroup of patients with right hemisphere stroke; lateropulsion and greater leg weakness may account for differences. Patients with lateropulsion may require longer rehabilitation to reach outcome goals.
Asunto(s)
Trastornos Neurológicos de la Marcha/diagnóstico , Trastornos Neurológicos de la Marcha/rehabilitación , Trastornos del Movimiento/diagnóstico , Trastornos del Movimiento/rehabilitación , Rehabilitación de Accidente Cerebrovascular , Accidente Cerebrovascular/complicaciones , Actividades Cotidianas , Anciano , Estudios de Casos y Controles , Infarto Cerebral/complicaciones , Infarto Cerebral/fisiopatología , Infarto Cerebral/rehabilitación , Evaluación de la Discapacidad , Terapia por Ejercicio/estadística & datos numéricos , Femenino , Lateralidad Funcional/fisiología , Trastornos Neurológicos de la Marcha/fisiopatología , Humanos , Pierna/inervación , Pierna/fisiopatología , Masculino , Trastornos del Movimiento/fisiopatología , Debilidad Muscular/diagnóstico , Debilidad Muscular/fisiopatología , Debilidad Muscular/rehabilitación , Modalidades de Fisioterapia/estadística & datos numéricos , Equilibrio Postural , Pronóstico , Recuperación de la Función/fisiología , Estudios Retrospectivos , Trastornos Somatosensoriales/diagnóstico , Trastornos Somatosensoriales/fisiopatología , Trastornos Somatosensoriales/rehabilitación , Accidente Cerebrovascular/fisiopatología , Resultado del TratamientoRESUMEN
BACKGROUND: Stroke incidence is greater in blacks than in whites; data on Hispanics are limited. Comparing subtype-specific ischemic stroke incidence rates may help to explain race-ethnic differences in stroke risk. The aim of this population-based study was to determine ischemic stroke subtype incidence rates for whites, blacks, and Hispanics living in one community. METHODS AND RESULTS: A comprehensive stroke surveillance system incorporating multiple overlapping strategies was used to identify all cases of first ischemic stroke occurring between July 1, 1993, and June 30, 1997, in northern Manhattan. Ischemic stroke subtypes were determined according to a modified NINDS scheme, and age-adjusted, race-specific incidence rates calculated. The annual age-adjusted incidence of first ischemic stroke per 100,000 was 88 (95% CI, 75 to 101) in whites, 149 (95% CI, 132 to 165) in Hispanics, and 191 (95% CI, 160 to 221) in blacks. Among blacks compared with whites, the relative rate of intracranial atherosclerotic stroke was 5.85 (95% CI, 1.82 to 18.73); extracranial atherosclerotic stroke, 3.18 (95% CI, 1.42 to 7.13); lacunar stroke, 3.09 (95% CI, 1.86 to 5.11); and cardioembolic stroke, 1.58 (95% CI, 0.99 to 2.52). Among Hispanics compared with whites, the relative rate of intracranial atherosclerotic stroke was 5.00 (95% CI, 1.69 to 14.76); extracranial atherosclerotic stroke, 1.71 (95% CI, 0.80 to 3.63); lacunar stroke, 2.32 (95% CI, 1.48 to 3.63); and cardioembolic stroke, 1.42 (95% CI, 0.97 to 2.09). CONCLUSIONS: The high ischemic stroke incidence among blacks and Hispanics compared with whites is due to higher rates of all ischemic stroke subtypes.
Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , Isquemia Encefálica/etnología , Hispánicos o Latinos/estadística & datos numéricos , Población Blanca/estadística & datos numéricos , Edad de Inicio , Anciano , Fibrilación Atrial/complicaciones , Fibrilación Atrial/etnología , Infarto Encefálico/etnología , Isquemia Encefálica/clasificación , Estudios de Cohortes , Comorbilidad , Femenino , Humanos , Incidencia , Arteriosclerosis Intracraneal/etnología , Embolia Intracraneal/etnología , Masculino , Persona de Mediana Edad , Ciudad de Nueva York/epidemiología , Vigilancia de la Población , Estudios Retrospectivos , Factores de Riesgo , Resultado del TratamientoRESUMEN
PURPOSE OF REVIEW: This article summarizes the most common neurologic sequelae of acute and chronic liver failure, liver transplantation, and other treatments for liver disease, and outlines the pathogenesis, neurologic manifestations, and treatment of Wilson disease. RECENT FINDINGS: The neurologic manifestations of liver disease are caused by the liver's failure to detoxify active compounds that have deleterious effects on the central and peripheral nervous systems. In addition, treatments for liver disease such as liver transplantation, transjugular intrahepatic portosystemic shunt, and antiviral medications can also be neurotoxic. Wilson disease affects the liver and nervous system simultaneously and may often initially be diagnosed by a neurologist; treatment options have evolved over recent years. SUMMARY: Acute and chronic liver diseases are encountered commonly in the general population. Neurologic dysfunction will eventually affect a significant number of these individuals, especially if the disease progresses to liver failure. Early recognition of these neurologic manifestations can lead to more effective management of these patients.
Asunto(s)
Hepatopatías/complicaciones , Enfermedades del Sistema Nervioso/etiología , Anciano , Femenino , Humanos , Masculino , Persona de Mediana EdadAsunto(s)
Trombosis del Seno Cavernoso/complicaciones , Trombosis del Seno Cavernoso/diagnóstico por imagen , Malformaciones Vasculares del Sistema Nervioso Central/complicaciones , Malformaciones Vasculares del Sistema Nervioso Central/diagnóstico por imagen , Angiografía Cerebral , Hemorragia Cerebral/diagnóstico , Disfunción Cognitiva/etiología , Tálamo/patología , Anticoagulantes/uso terapéutico , Hemorragia Cerebral/complicaciones , Cognición , Disfunción Cognitiva/patología , Confusión/etiología , Depresión/etiología , Diagnóstico Diferencial , Trastornos de Somnolencia Excesiva/etiología , Embolización Terapéutica , Fatiga/etiología , Cefalea/etiología , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Marruecos , Tálamo/diagnóstico por imagen , Tálamo/lesionesRESUMEN
The metabolic syndrome (MetS) is a distinctive phenotype associated with an increased risk of vascular disease. Carotid plaque is a surrogate marker of subclinical atherosclerosis and a powerful predictor of vascular outcomes. The relationship between the MetS and subclinical atherosclerosis in multiethnic populations has not been well characterized. The authors have evaluated the association of the MetS with subclinical atherosclerosis among 1895 community residents from the Northern Manhattan Study (mean age, 68.0+/-9.7 years; 59% women; 25% black; 22% white; 51% Hispanic). The prevalence of the MetS was 41% (35% in men, 45% in women), and 57% of subjects had carotid plaque. In a multivariate-adjusted logistic regression model, the MetS was a significant predictor of plaque presence (odds ratio, 1.36; 95% confidence interval, 1.10-1.67). Additionally, the number of MetS components was significantly associated with plaque prevalence. Further studies are needed to understand the role of the MetS in the progression from subclinical to clinical atherosclerotic disease.